Effect of probenecid on the urinary excretion of TXB2 and PGE2 in the anaesthetised rat
| Autor: | J. Haylor, J.D. Towers, C.J. Lote, A. Thewles |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Male
medicine.medical_specialty Urinary system Clinical Biochemistry Blood Pressure Urine Dinoprostone Excretion Kidney Tubules Proximal chemistry.chemical_compound Uricosuric Agent Internal medicine medicine Animals Probenecid Cell Biology respiratory system Rats Thromboxane B2 Endocrinology chemistry Eicosanoid Renal physiology lipids (amino acids peptides and proteins) p-Aminohippuric Acid medicine.drug |
| Zdroj: | Prostaglandins, leukotrienes, and essential fatty acids. 39(4) |
| ISSN: | 0952-3278 |
| Popis: | In the anaesthetised rat, probenecid (33 mg/kg) produced a 50% fall in urinary TXB2 excretion indicating that a componnt of the TXB2 excreted in the urine is secreted by the proximal tubule. At a higher dose of probenecid (100 mg/kg) this effect was overcome, a relative increase in urinary TXB2 excretion being produced. This may provide evidence for the proximal reabsorption or bi-directional transport of TXB2 in the rat. At 100 mg/kg probenecid also produced an 8-fold increase in urinary PGE2 excretion. Although the bi-directional transport of PGE2 is well known, this is the first time urinary PGE2 excretion rate has been shown to be modified by probenecid. The increase in PGE2 excretion could obscure the assessment of any inhibition by probenecid of proximal PGE2 secretion. It could also provide evidence for the proximal reabsorption of PGE2. However the interpretation of probenecid-induced changes in eicosanoid excretion in terms of modified tubular reabsorption must be treated with caution since urinary eicosanoid excretion could be increased by other properties of probenecid including inhibition of either protein binding or the uptake of eicosanoids into the lung. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|